跳至主要内容
临床试验/ACTRN12621000062820
ACTRN12621000062820已完成4 期

Effectiveness and safety of large bolus intramuscular naloxone for opioid poisoning in the Emergency Department: A randomised controlled trial

Princess Alexandra Hospital Clinical Toxicology Unit0 个研究点目标入组 136 人开始时间: 2021年1月25日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
136

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adult patients > 17 years old presenting to the Princess Alexandra Hospital Emergency Department that require naloxone to reverse respiratory depression (defined as a respiratory rate < 10 or oxygen saturations < 93%) due to suspected opioid poisoning

排除标准

  • Patients in which intravenous access is unable to be obtained
  • Patients who have iatrogenic poisoning following opioid administration for acute pain
  • Patients who are intubated and ventilated for management of concurrent conditions such as aspiration pneumonitis or to facilitate management of co-ingestions agents.
  • Patients in police or corrections custody

研究者

发起方
Princess Alexandra Hospital Clinical Toxicology Unit

相似试验